Apellis Pharmaceuticals Inc. (APLS) price may drop as it broke higher Bollinger Band on Oct 13, 2023. The company has a Bullish sentiment reading. Wall Street Analysts Think 67.65% Wall.

Apellis Pharmaceuticals Inc. (APLS) stock has risen 9% while the S&P 500 has fallen -0.6% as of 1:14 PM on Friday, Oct 13. The company has a Bullish sentiment reading. Wall Street Analysts Think 67.65% The mean of analysts price targets for Apellis Pharmaceuticals, Inc. (apls) stock price, news, quote & history - yahoo finance.com Insider Sell: Pascal Deschatelets Sells 12,000 Shares. Apellis Pharmaceuticals Inc (APLS) price may drop as it broke higher Bollinger Band on Oct 13, 2023. This price move could be a signal that APLS may fall back below the higher band. Apellis Pharmaceuticals, Inc. (APLS) Investors have opportunity to lead a class action lawsuit against the Company. Apellis Pharmaceuticals traded as high as $50.49 and last traded at $49.47. The company has a market cap of $5.70 billion, a price-to-earnings ratio of -8.31. Hedge funds and other institutional investors have recently added to or reduced their stakes in APLS. Apellis Pharmaceuticals stock (NASDAQ: APLS) stock price, news, charts, stock research, profile. Daily Ratings & News for Apelli Pharmaceuticals. Complete the form below to receive the latest headlines.